First-in-human study of lomvastomig, a PD-1-TIM-3 bispecific antibody, in patients with advanced and/or metastatic solid tumors. [PDF]
Rohrberg KS +38 more
europepmc +1 more source
Antibody-based regimens targeting PD-1/PD-L1 and VEGF/VEGFR in advanced or metastatic NSCLC: a meta-analysis of RCTs. [PDF]
Mao W +6 more
europepmc +1 more source
Neutrophil in sepsis: functional aberration and regulated cell death. [PDF]
Liu L, Yang Y, Yang H, Yang M.
europepmc +1 more source
Spindle Cell (Metaplastic) Carcinoma of the Breast Showing No Clinical Benefit with Pembrolizumab-Based Neoadjuvant Chemoimmunotherapy. [PDF]
Yamada R +10 more
europepmc +1 more source
Checkpoint blockade and the stem-like T cell trade-off. [PDF]
Mazet JM, Joyce JA.
europepmc +1 more source
Osteoarthritis and dementia: contrasting disorders driven by mutual pathways of autophagy, mTOR, GLP-1, AMPK, Wnt, and WISP1. [PDF]
Maiese K.
europepmc +1 more source
Blood-based kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage NSCLC: the prospective IOpener study. [PDF]
de Joode K +17 more
europepmc +1 more source
Sentinel Lymph Node Analysis in Patients With Breast Cancer Revealed Alterations in T Cells Subset. [PDF]
Cunha-Silva ME +6 more
europepmc +1 more source
The role of different types of programmed cell death in myocardial fibrosis: from mechanisms to therapeutics. [PDF]
Wang L, Lu G, Xiang L, Fan Y, Liu K.
europepmc +1 more source
Immune checkpoint blockade as an accelerator of adrenal aging: a testable model linking low-grade cortical inflammation to proteostasis failure, LDLR/SULT2A1 suppression, and reduced DHEA output. [PDF]
Ding G, Xu Y, Guo T, Feng C.
europepmc +1 more source

